Replies to post #444303 on Amarin Corp Plc (AMRN)

[rick25]

This PR is about payer positioning, not chasing generics. Emphasizing sHTG/MARINE highlights VASCEPA as the logical first-line step before higher-cost injectables. Proven data still matters.

[rosemountbomber]

That press release costs them nothing.